India Market Bug Bites Mylan As It Sets Sights On Stage-Wise Product Rollouts
This article was originally published in The Pink Sheet Daily
Executive Summary
Following on the hefty deal struck last week between Abbott and Piramal Healthcare for the Indian firm's generics business, U.S. generics leader Mylan prepares to enter the Indian formulations market in a big way.